We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Glossary Definition

EXPANDED ACCESS
A process regulated by the Food and Drug Administration (FDA) that allows manufacturers to provide investigational new drugs to patients with serious diseases or conditions who cannot participate in a clinical trial. One of several Study Types.

For more information on expanded access, visit the Expanded Access: Information for Patients page on the FDA Web site.